Global Generic Medicine Market Insights and Forecast to 2028

Global Generic Medicine Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Simple Generic Drugs
1.2.3 Super Generic Drugs
1.2.4 Biosimilars
1.2.5 By Application:
1.2.6 CNS
1.2.7 Cardiovascular
1.2.8 Respiratory
1.2.9 Rheumatology
1.2.10 Diabetes
1.2.11 Oncology
1.3 Market by Application
1.3.1 Global Generic Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Respiratory
1.3.5 Rheumatology
1.3.6 Diabetes
1.3.7 Oncology
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Generic Medicine Market Perspective (2017-2028)
2.2 Generic Medicine Growth Trends by Region
2.2.1 Generic Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Generic Medicine Historic Market Size by Region (2017-2022)
2.2.3 Generic Medicine Forecasted Market Size by Region (2023-2028)
2.3 Generic Medicine Market Dynamics
2.3.1 Generic Medicine Industry Trends
2.3.2 Generic Medicine Market Drivers
2.3.3 Generic Medicine Market Challenges
2.3.4 Generic Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Medicine Players by Revenue
3.1.1 Global Top Generic Medicine Players by Revenue (2017-2022)
3.1.2 Global Generic Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Generic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Medicine Revenue
3.4 Global Generic Medicine Market Concentration Ratio
3.4.1 Global Generic Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Medicine Revenue in 2021
3.5 Generic Medicine Key Players Head office and Area Served
3.6 Key Players Generic Medicine Product Solution and Service
3.7 Date of Enter into Generic Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Medicine Breakdown Data by Type
4.1 Global Generic Medicine Historic Market Size by Type (2017-2022)
4.2 Global Generic Medicine Forecasted Market Size by Type (2023-2028)
5 Generic Medicine Breakdown Data by Application
5.1 Global Generic Medicine Historic Market Size by Application (2017-2022)
5.2 Global Generic Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Generic Medicine Market Size (2017-2028)
6.2 North America Generic Medicine Market Size by Type
6.2.1 North America Generic Medicine Market Size by Type (2017-2022)
6.2.2 North America Generic Medicine Market Size by Type (2023-2028)
6.2.3 North America Generic Medicine Market Share by Type (2017-2028)
6.3 North America Generic Medicine Market Size by Application
6.3.1 North America Generic Medicine Market Size by Application (2017-2022)
6.3.2 North America Generic Medicine Market Size by Application (2023-2028)
6.3.3 North America Generic Medicine Market Share by Application (2017-2028)
6.4 North America Generic Medicine Market Size by Country
6.4.1 North America Generic Medicine Market Size by Country (2017-2022)
6.4.2 North America Generic Medicine Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Generic Medicine Market Size (2017-2028)
7.2 Europe Generic Medicine Market Size by Type
7.2.1 Europe Generic Medicine Market Size by Type (2017-2022)
7.2.2 Europe Generic Medicine Market Size by Type (2023-2028)
7.2.3 Europe Generic Medicine Market Share by Type (2017-2028)
7.3 Europe Generic Medicine Market Size by Application
7.3.1 Europe Generic Medicine Market Size by Application (2017-2022)
7.3.2 Europe Generic Medicine Market Size by Application (2023-2028)
7.3.3 Europe Generic Medicine Market Share by Application (2017-2028)
7.4 Europe Generic Medicine Market Size by Country
7.4.1 Europe Generic Medicine Market Size by Country (2017-2022)
7.4.2 Europe Generic Medicine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Medicine Market Size (2017-2028)
8.2 Asia-Pacific Generic Medicine Market Size by Type
8.2.1 Asia-Pacific Generic Medicine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Generic Medicine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Generic Medicine Market Share by Type (2017-2028)
8.3 Asia-Pacific Generic Medicine Market Size by Application
8.3.1 Asia-Pacific Generic Medicine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Generic Medicine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Generic Medicine Market Share by Application (2017-2028)
8.4 Asia-Pacific Generic Medicine Market Size by Region
8.4.1 Asia-Pacific Generic Medicine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Generic Medicine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Generic Medicine Market Size (2017-2028)
9.2 Latin America Generic Medicine Market Size by Type
9.2.1 Latin America Generic Medicine Market Size by Type (2017-2022)
9.2.2 Latin America Generic Medicine Market Size by Type (2023-2028)
9.2.3 Latin America Generic Medicine Market Share by Type (2017-2028)
9.3 Latin America Generic Medicine Market Size by Application
9.3.1 Latin America Generic Medicine Market Size by Application (2017-2022)
9.3.2 Latin America Generic Medicine Market Size by Application (2023-2028)
9.3.3 Latin America Generic Medicine Market Share by Application (2017-2028)
9.4 Latin America Generic Medicine Market Size by Country
9.4.1 Latin America Generic Medicine Market Size by Country (2017-2022)
9.4.2 Latin America Generic Medicine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Medicine Market Size (2017-2028)
10.2 Middle East & Africa Generic Medicine Market Size by Type
10.2.1 Middle East & Africa Generic Medicine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Generic Medicine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Generic Medicine Market Share by Type (2017-2028)
10.3 Middle East & Africa Generic Medicine Market Size by Application
10.3.1 Middle East & Africa Generic Medicine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Generic Medicine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Generic Medicine Market Share by Application (2017-2028)
10.4 Middle East & Africa Generic Medicine Market Size by Country
10.4.1 Middle East & Africa Generic Medicine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Generic Medicine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Generic Medicine Introduction
11.1.4 Teva Revenue in Generic Medicine Business (2017-2022)
11.1.5 Teva Recent Developments
11.2 Novartis - Sandoz
11.2.1 Novartis - Sandoz Company Details
11.2.2 Novartis - Sandoz Business Overview
11.2.3 Novartis - Sandoz Generic Medicine Introduction
11.2.4 Novartis - Sandoz Revenue in Generic Medicine Business (2017-2022)
11.2.5 Novartis - Sandoz Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Generic Medicine Introduction
11.3.4 Mylan Revenue in Generic Medicine Business (2017-2022)
11.3.5 Mylan Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Generic Medicine Introduction
11.4.4 Sun Pharmaceutical Revenue in Generic Medicine Business (2017-2022)
11.4.5 Sun Pharmaceutical Recent Developments
11.5 Aspen
11.5.1 Aspen Company Details
11.5.2 Aspen Business Overview
11.5.3 Aspen Generic Medicine Introduction
11.5.4 Aspen Revenue in Generic Medicine Business (2017-2022)
11.5.5 Aspen Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Generic Medicine Introduction
11.6.4 Fresenius Kabi Revenue in Generic Medicine Business (2017-2022)
11.6.5 Fresenius Kabi Recent Developments
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Details
11.7.2 Pfizer (Hospira) Business Overview
11.7.3 Pfizer (Hospira) Generic Medicine Introduction
11.7.4 Pfizer (Hospira) Revenue in Generic Medicine Business (2017-2022)
11.7.5 Pfizer (Hospira) Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Generic Medicine Introduction
11.8.4 Sanofi Revenue in Generic Medicine Business (2017-2022)
11.8.5 Sanofi Recent Developments
11.9 Aurobindo
11.9.1 Aurobindo Company Details
11.9.2 Aurobindo Business Overview
11.9.3 Aurobindo Generic Medicine Introduction
11.9.4 Aurobindo Revenue in Generic Medicine Business (2017-2022)
11.9.5 Aurobindo Recent Developments
11.10 Lupin
11.10.1 Lupin Company Details
11.10.2 Lupin Business Overview
11.10.3 Lupin Generic Medicine Introduction
11.10.4 Lupin Revenue in Generic Medicine Business (2017-2022)
11.10.5 Lupin Recent Developments
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Details
11.11.2 Dr. Reddy's Business Overview
11.11.3 Dr. Reddy's Generic Medicine Introduction
11.11.4 Dr. Reddy's Revenue in Generic Medicine Business (2017-2022)
11.11.5 Dr. Reddy's Recent Developments
11.12 Apotex
11.12.1 Apotex Company Details
11.12.2 Apotex Business Overview
11.12.3 Apotex Generic Medicine Introduction
11.12.4 Apotex Revenue in Generic Medicine Business (2017-2022)
11.12.5 Apotex Recent Developments
11.13 Cipla
11.13.1 Cipla Company Details
11.13.2 Cipla Business Overview
11.13.3 Cipla Generic Medicine Introduction
11.13.4 Cipla Revenue in Generic Medicine Business (2017-2022)
11.13.5 Cipla Recent Developments
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Details
11.14.2 ENDO (Par Pharmaceutical) Business Overview
11.14.3 ENDO (Par Pharmaceutical) Generic Medicine Introduction
11.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2017-2022)
11.14.5 ENDO (Par Pharmaceutical) Recent Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Details
11.15.2 Stada Arzneimittel Business Overview
11.15.3 Stada Arzneimittel Generic Medicine Introduction
11.15.4 Stada Arzneimittel Revenue in Generic Medicine Business (2017-2022)
11.15.5 Stada Arzneimittel Recent Developments
11.16 Krka Group
11.16.1 Krka Group Company Details
11.16.2 Krka Group Business Overview
11.16.3 Krka Group Generic Medicine Introduction
11.16.4 Krka Group Revenue in Generic Medicine Business (2017-2022)
11.16.5 Krka Group Recent Developments
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Details
11.17.2 Nichi-Iko Pharmaceutical Business Overview
11.17.3 Nichi-Iko Pharmaceutical Generic Medicine Introduction
11.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2017-2022)
11.17.5 Nichi-Iko Pharmaceutical Recent Developments
11.18 Valeant
11.18.1 Valeant Company Details
11.18.2 Valeant Business Overview
11.18.3 Valeant Generic Medicine Introduction
11.18.4 Valeant Revenue in Generic Medicine Business (2017-2022)
11.18.5 Valeant Recent Developments
11.19 Zydus Cadila
11.19.1 Zydus Cadila Company Details
11.19.2 Zydus Cadila Business Overview
11.19.3 Zydus Cadila Generic Medicine Introduction
11.19.4 Zydus Cadila Revenue in Generic Medicine Business (2017-2022)
11.19.5 Zydus Cadila Recent Developments
11.20 Hikma
11.20.1 Hikma Company Details
11.20.2 Hikma Business Overview
11.20.3 Hikma Generic Medicine Introduction
11.20.4 Hikma Revenue in Generic Medicine Business (2017-2022)
11.20.5 Hikma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Generic Medicine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Simple Generic Drugs
Table 3. Key Players of Super Generic Drugs
Table 4. Key Players of Biosimilars
Table 5. Key Players of By Application:
Table 6. Key Players of CNS
Table 7. Key Players of Cardiovascular
Table 8. Key Players of Respiratory
Table 9. Key Players of Rheumatology
Table 10. Key Players of Diabetes
Table 11. Key Players of Oncology
Table 12. Global Generic Medicine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 13. Global Generic Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 14. Global Generic Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 15. Global Generic Medicine Market Share by Region (2017-2022)
Table 16. Global Generic Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 17. Global Generic Medicine Market Share by Region (2023-2028)
Table 18. Generic Medicine Market Trends
Table 19. Generic Medicine Market Drivers
Table 20. Generic Medicine Market Challenges
Table 21. Generic Medicine Market Restraints
Table 22. Global Generic Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 23. Global Generic Medicine Revenue Share by Players (2017-2022)
Table 24. Global Top Generic Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Medicine as of 2021)
Table 25. Ranking of Global Top Generic Medicine Companies by Revenue (US$ Million) in 2021
Table 26. Global 5 Largest Players Market Share by Generic Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Generic Medicine Product Solution and Service
Table 29. Date of Enter into Generic Medicine Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Generic Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 32. Global Generic Medicine Revenue Market Share by Type (2017-2022)
Table 33. Global Generic Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 34. Global Generic Medicine Revenue Market Share by Type (2023-2028)
Table 35. Global Generic Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 36. Global Generic Medicine Revenue Share by Application (2017-2022)
Table 37. Global Generic Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 38. Global Generic Medicine Revenue Share by Application (2023-2028)
Table 39. North America Generic Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 40. North America Generic Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 41. North America Generic Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 42. North America Generic Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 43. North America Generic Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 44. North America Generic Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 45. Europe Generic Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 46. Europe Generic Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 47. Europe Generic Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 48. Europe Generic Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 49. Europe Generic Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 50. Europe Generic Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 51. Asia Pacific Generic Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 52. Asia Pacific Generic Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 53. Asia Pacific Generic Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 54. Asia Pacific Generic Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 55. Asia Pacific Generic Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 56. Asia Pacific Generic Medicine Market Size by Region (2023-2028) & (US$ Million)
Table 57. Latin America Generic Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 58. Latin America Generic Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 59. Latin America Generic Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 60. Latin America Generic Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 61. Latin America Generic Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 62. Latin America Generic Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Generic Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Generic Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 65. Middle East and Africa Generic Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 66. Middle East and Africa Generic Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 67. Middle East and Africa Generic Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 68. Middle East and Africa Generic Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 69. Teva Company Details
Table 70. Teva Business Overview
Table 71. Teva Generic Medicine Product
Table 72. Teva Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 73. Teva Recent Developments
Table 74. Novartis - Sandoz Company Details
Table 75. Novartis - Sandoz Business Overview
Table 76. Novartis - Sandoz Generic Medicine Product
Table 77. Novartis - Sandoz Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 78. Novartis - Sandoz Recent Developments
Table 79. Mylan Company Details
Table 80. Mylan Business Overview
Table 81. Mylan Generic Medicine Product
Table 82. Mylan Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 83. Mylan Recent Developments
Table 84. Sun Pharmaceutical Company Details
Table 85. Sun Pharmaceutical Business Overview
Table 86. Sun Pharmaceutical Generic Medicine Product
Table 87. Sun Pharmaceutical Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 88. Sun Pharmaceutical Recent Developments
Table 89. Aspen Company Details
Table 90. Aspen Business Overview
Table 91. Aspen Generic Medicine Product
Table 92. Aspen Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 93. Aspen Recent Developments
Table 94. Fresenius Kabi Company Details
Table 95. Fresenius Kabi Business Overview
Table 96. Fresenius Kabi Generic Medicine Product
Table 97. Fresenius Kabi Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 98. Fresenius Kabi Recent Developments
Table 99. Pfizer (Hospira) Company Details
Table 100. Pfizer (Hospira) Business Overview
Table 101. Pfizer (Hospira) Generic Medicine Product
Table 102. Pfizer (Hospira) Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 103. Pfizer (Hospira) Recent Developments
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Generic Medicine Product
Table 107. Sanofi Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 108. Sanofi Recent Developments
Table 109. Aurobindo Company Details
Table 110. Aurobindo Business Overview
Table 111. Aurobindo Generic Medicine Product
Table 112. Aurobindo Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 113. Aurobindo Recent Developments
Table 114. Lupin Company Details
Table 115. Lupin Business Overview
Table 116. Lupin Generic Medicine Product
Table 117. Lupin Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 118. Lupin Recent Developments
Table 119. Dr. Reddy's Company Details
Table 120. Dr. Reddy's Business Overview
Table 121. Dr. Reddy's Generic Medicine Product
Table 122. Dr. Reddy's Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 123. Dr. Reddy's Recent Developments
Table 124. Apotex Company Details
Table 125. Apotex Business Overview
Table 126. Apotex Generic Medicine Product
Table 127. Apotex Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 128. Apotex Recent Developments
Table 129. Cipla Company Details
Table 130. Cipla Business Overview
Table 131. Cipla Generic Medicine Product
Table 132. Cipla Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 133. Cipla Recent Developments
Table 134. ENDO (Par Pharmaceutical) Company Details
Table 135. ENDO (Par Pharmaceutical) Business Overview
Table 136. ENDO (Par Pharmaceutical) Generic Medicine Product
Table 137. ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 138. ENDO (Par Pharmaceutical) Recent Developments
Table 139. Stada Arzneimittel Company Details
Table 140. Stada Arzneimittel Business Overview
Table 141. Stada Arzneimittel Generic Medicine Product
Table 142. Stada Arzneimittel Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 143. Stada Arzneimittel Recent Developments
Table 144. Krka Group Company Details
Table 145. Krka Group Business Overview
Table 146. Krka Group Generic Medicine Product
Table 147. Krka Group Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 148. Krka Group Recent Developments
Table 149. Nichi-Iko Pharmaceutical Company Details
Table 150. Nichi-Iko Pharmaceutical Business Overview
Table 151. Nichi-Iko Pharmaceutical Generic Medicine Product
Table 152. Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 153. Nichi-Iko Pharmaceutical Recent Developments
Table 154. Valeant Company Details
Table 155. Valeant Business Overview
Table 156. Valeant Generic Medicine Product
Table 157. Valeant Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 158. Valeant Recent Developments
Table 159. Zydus Cadila Company Details
Table 160. Zydus Cadila Business Overview
Table 161. Zydus Cadila Generic Medicine Product
Table 162. Zydus Cadila Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 163. Zydus Cadila Recent Developments
Table 164. Hikma Company Details
Table 165. Hikma Business Overview
Table 166. Hikma Generic Medicine Product
Table 167. Hikma Revenue in Generic Medicine Business (2017-2022) & (US$ Million)
Table 168. Hikma Recent Developments
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Medicine Market Share by Type: 2021 VS 2028
Figure 2. Simple Generic Drugs Features
Figure 3. Super Generic Drugs Features
Figure 4. Biosimilars Features
Figure 5. By Application: Features
Figure 6. CNS Features
Figure 7. Cardiovascular Features
Figure 8. Respiratory Features
Figure 9. Rheumatology Features
Figure 10. Diabetes Features
Figure 11. Oncology Features
Figure 12. Global Generic Medicine Market Share by Application: 2021 VS 2028
Figure 13. CNS Case Studies
Figure 14. Cardiovascular Case Studies
Figure 15. Respiratory Case Studies
Figure 16. Rheumatology Case Studies
Figure 17. Diabetes Case Studies
Figure 18. Oncology Case Studies
Figure 19. Others Case Studies
Figure 20. Generic Medicine Report Years Considered
Figure 21. Global Generic Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 22. Global Generic Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 23. Global Generic Medicine Market Share by Region: 2021 VS 2028
Figure 24. Global Generic Medicine Market Share by Players in 2021
Figure 25. Global Top Generic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Medicine as of 2021)
Figure 26. The Top 10 and 5 Players Market Share by Generic Medicine Revenue in 2021
Figure 27. North America Generic Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 28. North America Generic Medicine Market Size Market Share by Type (2017-2028)
Figure 29. North America Generic Medicine Market Size Market Share by Application (2017-2028)
Figure 30. North America Generic Medicine Market Size Share by Country (2017-2028)
Figure 31. United States Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Canada Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Europe Generic Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Europe Generic Medicine Market Size Market Share by Type (2017-2028)
Figure 35. Europe Generic Medicine Market Size Market Share by Application (2017-2028)
Figure 36. Europe Generic Medicine Market Size Share by Country (2017-2028)
Figure 37. Germany Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. France Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. U.K. Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Italy Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Russia Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Nordic Countries Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Asia-Pacific Generic Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Asia Pacific Generic Medicine Market Size Market Share by Type (2017-2028)
Figure 45. Asia Pacific Generic Medicine Market Size Market Share by Application (2017-2028)
Figure 46. Asia Pacific Generic Medicine Market Size Share by Region (2017-2028)
Figure 47. China Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Japan Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. South Korea Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Southeast Asia Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. India Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Australia Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 53. Latin America Generic Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 54. Latin America Generic Medicine Market Size Market Share by Type (2017-2028)
Figure 55. Latin America Generic Medicine Market Size Market Share by Application (2017-2028)
Figure 56. Latin America Generic Medicine Market Size Share by Country (2017-2028)
Figure 57. Mexico Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Brazil Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Middle East & Africa Generic Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 60. Middle East and Africa Generic Medicine Market Size Market Share by Type (2017-2028)
Figure 61. Middle East and Africa Generic Medicine Market Size Market Share by Application (2017-2028)
Figure 62. Middle East and Africa Generic Medicine Market Size Share by Country (2017-2028)
Figure 63. Turkey Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 64. Saudi Arabia Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 65. UAE Generic Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 66. Teva Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 67. Novartis - Sandoz Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 68. Mylan Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 69. Sun Pharmaceutical Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 70. Aspen Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 71. Fresenius Kabi Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 72. Pfizer (Hospira) Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 73. Sanofi Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 74. Aurobindo Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 75. Lupin Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 76. Dr. Reddy's Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 77. Apotex Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 78. Cipla Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 79. ENDO (Par Pharmaceutical) Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 80. Stada Arzneimittel Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 81. Krka Group Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 82. Nichi-Iko Pharmaceutical Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 83. Valeant Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 84. Zydus Cadila Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 85. Hikma Revenue Growth Rate in Generic Medicine Business (2017-2022)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs